Company Executives

Interim Executive Chairman of the Board

Chief Executive Officer

Managing Director

Age 52

Compensation -

Sex Male

Chief Financial Officer

Age -

Compensation -

Sex Female

Clinical & Regulatory Affairs Manager

Age -

Compensation -

Sex Female

Chief Business Officer

Age -

Compensation -

Sex Male

Company Secretary

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Dr. John Friend Interim Executive Chairman of the Board Chief Executive Officer Managing Director	52	-	Male
Ms. Karen Krumeich Chief Financial Officer	-	-	Female
Lilischkis Kimberley Clinical & Regulatory Affairs Manager	-	-	Female
Mr. Peng Leong Chief Business Officer	-	-	Male
Ms. Anna Sandham Company Secretary	-	-	Female

Board of Directors

Board of Directors comes from the company’s proxy statement. Kazia Therapeutics Ltd has not filed one with the SEC.

Related-party transactions come from the company’s proxy statement. Kazia Therapeutics Ltd has not filed one with the SEC.

Comments